Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

0.3107 -0.0230 (-6.89%)

Streaming Delayed Price Updated: 12:53 PM EDT, May 27, 2026 Add to My Watchlist

Price and Volume

Volume	52,843,870
Open	0.3644
Bid (Size)	0.3107 (100)
Ask (Size)	0.3108 (400)
Prev. Close	0.3337
Today's Range	0.2995 - 0.3644
52wk Range	0.2000 - 3.050
Shares Outstanding	584,908,239
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

May 12, 2026

From Mereo BioPharma Group plc

Via GlobeNewswire

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

April 06, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Performance

YTD	-39.1%	-39.1%
1 Month	+10.9%	+10.9%
3 Month	-21.9%	-21.9%
6 Month	-82.6%	-82.6%
1 Year	-85.7%	-85.7%

More News

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

April 06, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

April 06, 2026

From Schall Law

Via GlobeNewswire

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

April 03, 2026

From Rosen Law Firm

Via Business Wire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

April 02, 2026

From Schall Law

Via GlobeNewswire

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

April 01, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

March 31, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

March 30, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

March 26, 2026

From Berger Montague

Via GlobeNewswire

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

March 25, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

March 25, 2026

From Robbins LLP

Via Business Wire

MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th

March 25, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

March 24, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

March 23, 2026

From Schall Law

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

March 19, 2026

From Schall Law

Via GlobeNewswire

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

March 19, 2026

From Mereo BioPharma Group plc

Via GlobeNewswire

MREO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

March 18, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

ROSEN, A TOP RANKED LAW FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

March 16, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

March 16, 2026

From Schall Law

Via GlobeNewswire

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

March 13, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

MREO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026

March 13, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Frequently Asked Questions

Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?

Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.

What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?

Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?

The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market

What is the current price of Mereo BioPharma Group plc - American Depositary Shares?

The current price of Mereo BioPharma Group plc - American Depositary Shares is 0.3107

When was Mereo BioPharma Group plc - American Depositary Shares last traded?

The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 05/27/26 12:53 PM ET

What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?

The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 181.73M

How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?

Mereo BioPharma Group plc - American Depositary Shares has 182M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.